Machine Learning Model Predicts Daily Infection Risk in Leukemia Chemotherapy Patients
Researchers in Finland have developed and validated a machine learning model that uses routine clinical data to predict the daily risk of febrile neutropenia in acute myeloid leukemia patients undergoing intensive chemotherapy.
Key points
- New machine learning model predicts daily febrile neutropenia risk in acute myeloid leukemia patients.
- The algorithm relies on seven routine clinical variables, including temperature and lab counts.
- Researchers tested the model using data from two Finnish university hospital districts.
Infections represent a major hurdle during intensive chemotherapy for acute myeloid leukemia, frequently driving up illness and mortality rates. To address the lack of early detection tools, investigators at Helsinki University Hospital and Turku University Hospital built and tested a machine learning algorithm to forecast the daily risk of febrile neutropenia over a 48-hour window.
The retrospective observational study utilized registry data from two university hospital districts in Finland, analyzing a cohort of adult patients with newly diagnosed acute myeloid leukemia. Utilizing the Extreme Gradient Boosting algorithm, the model evaluated 1.2 million clinical data points based on seven key variables: white blood cell count, body temperature, duration since the start of the treatment cycle, C-reactive protein trends, absolute neutrophil count, treatment phase, and prior antibiotic exposure. The development cohort achieved an area under the receiver operating characteristic curve of 0.91, while external validation yielded an area under the curve of 0.79.
What to know: While the findings suggest that routinely gathered metrics can help forecast acute infection risks, the tool remains in the research phase and requires prospective validation before it can be integrated into regular clinical workflows. Readers should consult qualified healthcare professionals regarding any personal medical decisions or cancer treatment plans.
Source Nature Health Sciences — nature.com/articles/s43856-026-02001-x ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…